Learning Objectives
By the end of this activity, the participant should be better able to:
| • | Apply the latest evidence on the use of clinical symptoms, imaging, and biomarkers to make an accurate early diagnosis of PD |
| • | Compare and contrast clinical study findings of potential disease-modifying agents, taking into consideration differing study designs |
| • | Identify the spectrum of clinical manifestations of PD in patient case scenarios, and develop individualized treatment plans based on the safety and efficacy of various therapeutic options |